We investigated the occurrence of multidrug resistance in 44 Enterobacter aerogenes and Klebsiella pneumoniae clinical isolates. Efflux was involved in resistance in E. aerogenes isolates more frequently than in K. pneumoniae isolates (100 versus 38% of isolates) and was associated with the expression of phenylalanine arginine -naphthylamide-susceptible active efflux. AcrA-TolC overproduction in E. aerogenes isolates was noted. An analysis of four E. aerogenes isolates for which cefepime MICs were high revealed no modification in porin expression but a new specific mutation in the AmpC -lactamase.Enterobacter aerogenes and Klebsiella pneumoniae, two of the most prevalent nosocomial enterobacterial species, can frequently express a multidrug resistance (MDR) phenotype by the acquisition or high-level production of -lactamases in combination with the overproduction of efflux pumps, associated or not with porin alterations in the outer membrane (1,3,7,9,13). Such modifications of envelope permeability, including efflux and influx (porin), in 28 Enterobacter aerogenes and 16 Klebsiella pneumoniae clinical isolates from Nîmes University Hospital, previously studied for extended-spectrum -lactamase (ESBL) profiling and clonal identification, were investigated (11). Moreover, we ascertained the mechanism involved in cefepime resistance in four E. aerogenes isolates showing high-level resistance (MIC ϭ 128 mg/liter).Characterization of the MDR phenotype was carried out by determining the MICs of various structurally unrelated antibiotics selected for their capacities to be expelled and/or to enter cells via porins (Table 1). We used the twofold broth dilution method with Mueller-Hinton broth according to the CLSI guidelines: the tests were carried out with or without the broad-spectrum efflux pump inhibitor (EPI) phenylalanine arginine -naphthylamide (PAN). This diamine compound, used at a low concentration (26.3 mg/liter), can increase the activities of chloramphenicol, tetracycline, norfloxacin, and sparfloxacin against various enterobacterial isolates which overproduce efflux pumps such AcrAB-TolC (4, 9, 16). The test results confirmed the existence of a PAN-susceptible efflux mechanism in all E. aerogenes and many K. pneumoniae strains, with marked decreases in the MICs of fluoroquinolones and chloramphenicol in the presence of PAN (Table 1). Efflux pump activity was identified when the PAN addition induced a threefold decrease in the MIC of an antibiotic molecule (4, 9). For the two fluoroquinolones, the PAN addition had better efficiency in decreasing the MICs of sparfloxacin than those of norfloxacin. The observed difference in PAN efflux inhibition between the two fluoroquinolones may reflect the respective locations of ligands inside the AcrB cavity and the flux competition (20). Yu et al. demonstrated, during previous cocrystalization analyses, the presence of different affinity sites located inside the AcrB pump and suggested that the benefit generated by the conjoint use of an EPI and an antibioti...